PERSPECTA

News from every angle

← Back to headlines

USFDA issues observation to Aurobindo Pharma's Telangana unit

Aurobindo Pharma's shares are under scrutiny after the USFDA issued an observation to its manufacturing unit located in Telangana.

24 Aug, 02:07 — 24 Aug, 02:07
PostShare

Sources

Showing 1 of 1 sources
moneycontrol1d ago

Aurobindo Pharma shares in focus after USFDA issues observation to Telangana unit - Moneycontrol.com

Aurobindo Pharma shares in focus after USFDA issues observation to Telangana unit  Moneycontrol.com

Read full article →

Related Stories

Countdown Begins for Greek Home Renovation Subsidies Up to €36,000

19m ago

Trump Buys SpaceX Shares Amid AI Concerns and Mail-in Ballot Ruling

36m ago

Tokio Marine Considers Suncorp Acquisition After Berkshire Stake

1h ago

Tuya Reports Second Quarter 2026 Unaudited Financial Results

1h ago